Lv65
2130 积分 2023-03-30 加入
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer
7天前
已完结
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer
7天前
已关闭
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
8天前
已完结
Characteristics of breast cancer in Central China, literature review and comparison with USA
10天前
已完结
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
14天前
已完结
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial
16天前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
17天前
已关闭
Accelerating drug development in breast cancer: New frontiers for ER inhibition
22天前
已完结
Positioning oral selective estrogen receptor degraders in patients with metastatic breast cancer
22天前
已完结
PI3K/AKT/mTOR信号通路抑制剂治疗乳腺癌临床应用专家共识
22天前
已完结
皖公网安备34019202002308
